Related Experiment Video
Updated: Apr 19, 2026

A Chromatin Immunoprecipitation Assay to Identify Novel NFAT2 Target Genes in Chronic Lymphocytic Leukemia
Published on: December 4, 2018
NFAT targets signaling molecules to gene promoters in pancreatic β-cells
Michael C Lawrence1, Nofit Borenstein-Auerbach, Kathleen McGlynn
1Islet Cell Laboratory (M.C.L., N.B.-A., F.K., R.S., I.S., M.T.), Baylor Research Institute, Dallas, Texas 75226; Department of Pharmacology (K.M.), University of Texas Southwestern Medical Center, Dallas, Texas 75390; Institute of Biomedical Studies (M.K.), Baylor University, Waco, Texas 76798; and Annette C. and Harold C. Simmons Transplant Institute (M.F.L., B.N.), Baylor University Medical Center, Dallas, Texas 75246.
Abstract:
Nuclear factor of activated T cells (NFAT) is activated by calcineurin in response to calcium signals derived by metabolic and inflammatory stress to regulate genes in pancreatic islets. Here, we show that NFAT targets MAPKs, histone acetyltransferase p300, and histone deacetylases (HDACs) to gene promoters to differentially regulate insulin and TNF-α genes. NFAT and ERK associated with the insulin gene promoter in response to glucagon-like peptide 1, whereas NFAT formed complexes with p38 MAPK (p38) and Jun N-terminal kinase (JNK) upon promoters of the TNF-α gene in response to IL-1β. Translocation of NFAT and MAPKs to gene promoters was calcineurin/NFAT dependent, and complex stability required MAPK activity. Knocking down NFATc2 expression, eliminating NFAT DNA binding sites, or interfering with NFAT nuclear import prevented association of MAPKs with gene promoters. Inhibiting p38 and JNK activity increased NFAT-ERK association with promoters, which repressed TNF-α and enhanced insulin gene expression. Moreover, inhibiting p38 and JNK induced a switch from NFAT-p38/JNK-histone acetyltransferase p300 to NFAT-ERK-HDAC3 complex formation upon the TNF-α promoter, which resulted in gene repression. Histone acetyltransferase/HDAC exchange was reversed on the insulin gene by p38/JNK inhibition in the presence of glucagon-like peptide 1, which enhanced gene expression. Overall, these data indicate that NFAT directs signaling enzymes to gene promoters in islets, which contribute to protein-DNA complex stability and promoter regulation. Furthermore, the data suggest that TNF-α can be repressed and insulin production can be enhanced by selectively targeting signaling components of NFAT-MAPK transcriptional/signaling complex formation in pancreatic β-cells. These findings have therapeutic potential for suppressing islet inflammation while preserving islet function in diabetes and islet transplantation.
Insights
Nuclear factor of activated T cells (NFAT) directs signaling enzymes to pancreatic islet genes, regulating insulin and TNF-α. Targeting NFAT-MAPK complexes may enhance insulin production and suppress inflammation in diabetes.
Area of Science:
- Molecular biology
- Cell signaling
- Endocrinology
Background:
- Nuclear factor of activated T cells (NFAT) activation by calcineurin responds to calcium signals in pancreatic islets.
- NFAT regulates gene expression influenced by metabolic and inflammatory stress.
Purpose of the Study:
- To elucidate the role of NFAT in directing signaling enzymes to gene promoters.
- To investigate NFAT's differential regulation of insulin and TNF-α genes.
- To explore therapeutic potential for targeting NFAT-MAPK complexes in pancreatic β-cells.
Main Methods:
- Investigated NFAT and MAPK interactions at insulin and TNF-α gene promoters.
- Utilized calcineurin/NFAT-dependent translocation assays.
- Employed gene knockdown, DNA binding site elimination, and nuclear import interference.
- Assessed effects of p38 and JNK inhibition on complex formation and gene expression.
Main Results:
- NFAT targets MAPKs, p300, and HDACs to regulate insulin and TNF-α genes.
- NFAT-ERK associates with the insulin promoter (GLP-1), while NFAT-p38/JNK associate with the TNF-α promoter (IL-1β).
- Inhibition of p38/JNK enhances insulin expression and represses TNF-α by altering NFAT-MAPK-epigenetic modifier complexes.
Conclusions:
- NFAT directs signaling enzymes to islet gene promoters, stabilizing protein-DNA complexes and regulating gene expression.
- Selective targeting of NFAT-MAPK components can enhance insulin production and suppress TNF-α.
- Findings suggest therapeutic strategies for diabetes and islet transplantation by modulating islet inflammation and function.
More Related Videos
Related Concept Videos
Cell Specific Gene Expression
Canonical Wnt Signaling Pathway
NF-κB-dependent Signaling Pathway
NF-κB-dependent Signaling Mechanism
The...
TGF - β Signaling Pathway
Non-Canonical Wnt Signaling Pathways
Hormones Regulating Blood Glucose
In addition to accelerating glucose uptake and utilization, insulin has...

